CA2134877A1 - Usage d'heteropolytungstates pour le traitement d'infections par des flavivirus - Google Patents

Usage d'heteropolytungstates pour le traitement d'infections par des flavivirus

Info

Publication number
CA2134877A1
CA2134877A1 CA002134877A CA2134877A CA2134877A1 CA 2134877 A1 CA2134877 A1 CA 2134877A1 CA 002134877 A CA002134877 A CA 002134877A CA 2134877 A CA2134877 A CA 2134877A CA 2134877 A1 CA2134877 A1 CA 2134877A1
Authority
CA
Canada
Prior art keywords
pharmaceutically acceptable
compounds
znii
coii
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002134877A
Other languages
English (en)
Inventor
Helmut Weigold
Angeline Ingrid Bartholomeusz
George Holan
Sebastian Mario Marcuccio
Peter James Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2134877A1 publication Critical patent/CA2134877A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002134877A 1992-05-01 1993-04-30 Usage d'heteropolytungstates pour le traitement d'infections par des flavivirus Abandoned CA2134877A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL221392 1992-05-01
AUPL2213 1992-05-01

Publications (1)

Publication Number Publication Date
CA2134877A1 true CA2134877A1 (fr) 1993-11-11

Family

ID=3776137

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002134877A Abandoned CA2134877A1 (fr) 1992-05-01 1993-04-30 Usage d'heteropolytungstates pour le traitement d'infections par des flavivirus

Country Status (6)

Country Link
JP (1) JPH07506352A (fr)
CN (1) CN1082892A (fr)
CA (1) CA2134877A1 (fr)
HU (1) HUT71677A (fr)
MX (1) MX9302578A (fr)
WO (1) WO1993021934A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824706A (en) * 1994-09-26 1998-10-20 Schinazi; Raymond F. Method, compositions, and apparatus for treating and preventing respiratory viral infections
AUPO820197A0 (en) * 1997-07-24 1997-08-14 Biomolecular Research Institute Limited Inorganic angiogenesis inhibitors
AUPO995297A0 (en) * 1997-10-24 1997-11-13 Starpharma Limited Inorganic antiviral compounds
CN1325309A (zh) * 1998-08-21 2001-12-05 维洛药品公司 用于治疗或预防病毒感染和相关疾病的化合物、组合物和方法
DE102006023394A1 (de) * 2006-05-17 2007-11-22 Gerd Prof. Wengler Herstellung und Verwendung eines antiviralen Chemotherapeutikums welches eine Wirtszelle dahingehend beeinflusst, dass die Replikation von Viren in der Zelle blockiert wird
CN107226462A (zh) * 2016-03-24 2017-10-03 李泽琳 多酸化合物、其制备方法和医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2117803B1 (fr) * 1970-12-18 1974-03-22 Anvar
EP0450065A4 (en) * 1988-12-16 1992-01-02 Terumo Kabushiki Kaisha Antiviral agent
GB8906189D0 (en) * 1989-03-17 1989-05-04 Johnson Matthey Plc Improvements in chemical compounds
GB9003430D0 (en) * 1990-02-15 1990-04-11 Johnson Matthey Plc Improvements in chemical compounds
GB9025847D0 (en) * 1990-11-28 1991-01-09 Johnson Matthey Plc Improvements in chemical compounds

Also Published As

Publication number Publication date
MX9302578A (es) 1994-08-31
CN1082892A (zh) 1994-03-02
WO1993021934A1 (fr) 1993-11-11
HU9403128D0 (en) 1995-02-28
JPH07506352A (ja) 1995-07-13
HUT71677A (en) 1996-01-29

Similar Documents

Publication Publication Date Title
TWI515000B (zh) 用於治療病毒感染之化合物及醫藥組合物
JPS63107936A (ja) 後天性免疫不全症ａｉｄｓに対する医薬
AU1160597A (en) Benzamidoxime prodrugs as antipneumocystic agents
CN111265528A (zh) 法匹拉韦在治疗冠状病毒感染方面的应用
WO1995011033A1 (fr) Polyoxometallates utilises dans le traitement des infections associees au flavivirus
CA2134877A1 (fr) Usage d'heteropolytungstates pour le traitement d'infections par des flavivirus
JPH06505231A (ja) 癌またはエイズの治療におけるキノンの使用
CA1065251A (fr) Agent antiviral
JPS5817167B2 (ja) 抗ウイルス作用を有する医薬組成物
Shannon et al. 3-Deazauridine: inhibition of ribonucleic acid virus-induced cytopathogenic effects in vitro
JPS6328045B2 (fr)
JP2688057B2 (ja) 抗腺がん剤
EP2851368B1 (fr) Composés complexes de germanium, procédés de leur production et médicaments
WO1994012192A1 (fr) Agents antiviraux
NO313225B1 (no) Kombinasjon av atovaquon og proguanil for behandling av protozoinfeksjoner
RU2277908C1 (ru) Водорастворимое средство, обладающее противовирусной активностью, на основе соединения серебра с цистином и способ его получения
Donovick et al. On the action of thiosemicarbazones in experimental tuberculosis in the mouse
CN107865870A (zh) 作为ev71病毒和cav16病毒抑制剂的磷脂复合物的制备和应用
JPH0761946B2 (ja) エイズ・ウイルス増殖抑制剤
AU4255593A (en) Heteropolytungstates in the treatment of flavivirus infections
JP3002700B2 (ja) 抗エイズウイルス剤
CN113425711A (zh) 磺基琥珀酸酯盐在制备广谱抗病毒药物中的应用
CN111450109B (zh) 环腺苷酸及其衍生物在抗ev71病毒中的应用
JPH05504130A (ja) 腫瘍壊死因子拮抗剤
Israel et al. The effect of the prolonged administration of p-(di-n-propylsulfamyl)-benzoic acid (Benemid) upon plasma concentrations of para-aminosalicylic acid

Legal Events

Date Code Title Description
FZDE Discontinued